Stimulation of chitin synthesis rescues Candida albicans from echinocandins

Louise Walker, Carol A Munro, Irene De Bruijn, Megan D Lenardon, Alastair D McKinnon, Neil A R Gow

Research output: Contribution to journalArticle

207 Citations (Scopus)
10 Downloads (Pure)

Abstract

Echinocandins are a new generation of novel antifungal agent that inhibit cell wall beta(1,3)-glucan synthesis and are normally cidal for the human pathogen Candida albicans. Treatment of C. albicans with low levels of echinocandins stimulated chitin synthase (CHS) gene expression, increased Chs activity, elevated chitin content and reduced efficacy of these drugs. Elevation of chitin synthesis was mediated via the PKC, HOG, and Ca2+-calcineurin signalling pathways. Stimulation of Chs2p and Chs8p by activators of these pathways enabled cells to survive otherwise lethal concentrations of echinocandins, even in the absence of Chs3p and the normally essential Chs1p, which synthesize the chitinous septal ring and primary septum of the fungus. Under such conditions, a novel proximally offset septum was synthesized that restored the capacity for cell division, sustained the viability of the cell, and abrogated morphological and growth defects associated with echinocandin treatment and the chs mutations. These findings anticipate potential resistance mechanisms to echinocandins. However, echinocandins and chitin synthase inhibitors synergized strongly, highlighting the potential for combination therapies with greatly enhanced cidal activity.

Original languageEnglish
Article numbere1000040
Number of pages12
JournalPLoS Pathogens
Volume4
Issue number4
DOIs
Publication statusPublished - 8 Apr 2008

Keywords

  • protein-kinase-C
  • prosthetic valve endocarditis
  • antifungal drug caspofungin
  • cell-wall integrity
  • Saccharomyces-cerevisiae
  • reduced susceptibility
  • in-vitro
  • 1,3-beta-D-glucan synthase
  • cryptococcus-neoformans
  • aspergillus-fumigatus

Cite this

Stimulation of chitin synthesis rescues Candida albicans from echinocandins. / Walker, Louise; Munro, Carol A; De Bruijn, Irene; Lenardon, Megan D; McKinnon, Alastair D; Gow, Neil A R.

In: PLoS Pathogens, Vol. 4, No. 4, e1000040, 08.04.2008.

Research output: Contribution to journalArticle

Walker, Louise ; Munro, Carol A ; De Bruijn, Irene ; Lenardon, Megan D ; McKinnon, Alastair D ; Gow, Neil A R. / Stimulation of chitin synthesis rescues Candida albicans from echinocandins. In: PLoS Pathogens. 2008 ; Vol. 4, No. 4.
@article{cf1d6323a60f4d1d842fedf16a8fd42d,
title = "Stimulation of chitin synthesis rescues Candida albicans from echinocandins",
abstract = "Echinocandins are a new generation of novel antifungal agent that inhibit cell wall beta(1,3)-glucan synthesis and are normally cidal for the human pathogen Candida albicans. Treatment of C. albicans with low levels of echinocandins stimulated chitin synthase (CHS) gene expression, increased Chs activity, elevated chitin content and reduced efficacy of these drugs. Elevation of chitin synthesis was mediated via the PKC, HOG, and Ca2+-calcineurin signalling pathways. Stimulation of Chs2p and Chs8p by activators of these pathways enabled cells to survive otherwise lethal concentrations of echinocandins, even in the absence of Chs3p and the normally essential Chs1p, which synthesize the chitinous septal ring and primary septum of the fungus. Under such conditions, a novel proximally offset septum was synthesized that restored the capacity for cell division, sustained the viability of the cell, and abrogated morphological and growth defects associated with echinocandin treatment and the chs mutations. These findings anticipate potential resistance mechanisms to echinocandins. However, echinocandins and chitin synthase inhibitors synergized strongly, highlighting the potential for combination therapies with greatly enhanced cidal activity.",
keywords = "protein-kinase-C, prosthetic valve endocarditis, antifungal drug caspofungin, cell-wall integrity, Saccharomyces-cerevisiae, reduced susceptibility, in-vitro, 1,3-beta-D-glucan synthase, cryptococcus-neoformans, aspergillus-fumigatus",
author = "Louise Walker and Munro, {Carol A} and {De Bruijn}, Irene and Lenardon, {Megan D} and McKinnon, {Alastair D} and Gow, {Neil A R}",
year = "2008",
month = "4",
day = "8",
doi = "10.1371/journal.ppat.1000040",
language = "English",
volume = "4",
journal = "PLoS Pathogens",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Stimulation of chitin synthesis rescues Candida albicans from echinocandins

AU - Walker, Louise

AU - Munro, Carol A

AU - De Bruijn, Irene

AU - Lenardon, Megan D

AU - McKinnon, Alastair D

AU - Gow, Neil A R

PY - 2008/4/8

Y1 - 2008/4/8

N2 - Echinocandins are a new generation of novel antifungal agent that inhibit cell wall beta(1,3)-glucan synthesis and are normally cidal for the human pathogen Candida albicans. Treatment of C. albicans with low levels of echinocandins stimulated chitin synthase (CHS) gene expression, increased Chs activity, elevated chitin content and reduced efficacy of these drugs. Elevation of chitin synthesis was mediated via the PKC, HOG, and Ca2+-calcineurin signalling pathways. Stimulation of Chs2p and Chs8p by activators of these pathways enabled cells to survive otherwise lethal concentrations of echinocandins, even in the absence of Chs3p and the normally essential Chs1p, which synthesize the chitinous septal ring and primary septum of the fungus. Under such conditions, a novel proximally offset septum was synthesized that restored the capacity for cell division, sustained the viability of the cell, and abrogated morphological and growth defects associated with echinocandin treatment and the chs mutations. These findings anticipate potential resistance mechanisms to echinocandins. However, echinocandins and chitin synthase inhibitors synergized strongly, highlighting the potential for combination therapies with greatly enhanced cidal activity.

AB - Echinocandins are a new generation of novel antifungal agent that inhibit cell wall beta(1,3)-glucan synthesis and are normally cidal for the human pathogen Candida albicans. Treatment of C. albicans with low levels of echinocandins stimulated chitin synthase (CHS) gene expression, increased Chs activity, elevated chitin content and reduced efficacy of these drugs. Elevation of chitin synthesis was mediated via the PKC, HOG, and Ca2+-calcineurin signalling pathways. Stimulation of Chs2p and Chs8p by activators of these pathways enabled cells to survive otherwise lethal concentrations of echinocandins, even in the absence of Chs3p and the normally essential Chs1p, which synthesize the chitinous septal ring and primary septum of the fungus. Under such conditions, a novel proximally offset septum was synthesized that restored the capacity for cell division, sustained the viability of the cell, and abrogated morphological and growth defects associated with echinocandin treatment and the chs mutations. These findings anticipate potential resistance mechanisms to echinocandins. However, echinocandins and chitin synthase inhibitors synergized strongly, highlighting the potential for combination therapies with greatly enhanced cidal activity.

KW - protein-kinase-C

KW - prosthetic valve endocarditis

KW - antifungal drug caspofungin

KW - cell-wall integrity

KW - Saccharomyces-cerevisiae

KW - reduced susceptibility

KW - in-vitro

KW - 1,3-beta-D-glucan synthase

KW - cryptococcus-neoformans

KW - aspergillus-fumigatus

U2 - 10.1371/journal.ppat.1000040

DO - 10.1371/journal.ppat.1000040

M3 - Article

VL - 4

JO - PLoS Pathogens

JF - PLoS Pathogens

SN - 1553-7366

IS - 4

M1 - e1000040

ER -